SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,737,656 titled "Integration of Infusion Pump with Remote
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the launch of the t:lock™ Connector for its insulin pump cartridges and infusion sets.
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced enrollment of the first patients in an at-home pivotal trial for its t:slim X2™ Insulin Pump
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,715,327 titled "Preventing Inadvertent Changes in Ambulatory
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the 2017 Wedbush
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended June 30, 2017 .
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2017 results after the financial markets close on Thursday, July 27, 2017 .
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today presented results from a feasibility study for its predictive low glucose suspend (PLGS) algorithm,
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended March 31, 2017 .
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the Deutsche Bank 42
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its first quarter 2017 results after the financial markets close on Thursday, April 27, 2017 .
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the launch of the t:connect ® HCP Portal. The portal is an extension of the company's Mac- and
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock at a
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the year and quarter ended December 31, 2016 and provided financial
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced plans to implement a new infusion set connector for Tandem insulin pump cartridges and infusion
Software Update Available for all t:slim® Insulin Pumps Purchased Before April 2015 SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the release
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its fourth quarter and full year 2016 results after the financial markets close on Wednesday,
- Additional Presentation of Self-reported Data Demonstrates Reduced Risk of Hypoglycemia with Tandem Pumps Compared to Previous Therapy - SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. ( NASDAQ : TNDM) today announced that it has initiated the drawdown of $35 million under the company's previously announced term loan facility with Capital Royalty Partners II L.P. and its affiliated funds ("CRG").
